Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases
Serum chitinase-3-like protein 1 (CHI3L1) is a diagnostic marker for liver diseases, such as hepatocellular carcinoma (HCC). Herein, we aimed to evaluate the analytical performance of a chemiluminescent immunoassay (CLIA) for the quantitative detection of CHI3L1 and its application in hepatitis B vi...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | International Journal of Analytical Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2024/6688819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558433441677312 |
|---|---|
| author | Yanqiang Liao Se Peng Lesheng Huang Zhong Li Jian Hu Rui Xu Wenzhi Tang Jialing Zhuang |
| author_facet | Yanqiang Liao Se Peng Lesheng Huang Zhong Li Jian Hu Rui Xu Wenzhi Tang Jialing Zhuang |
| author_sort | Yanqiang Liao |
| collection | DOAJ |
| description | Serum chitinase-3-like protein 1 (CHI3L1) is a diagnostic marker for liver diseases, such as hepatocellular carcinoma (HCC). Herein, we aimed to evaluate the analytical performance of a chemiluminescent immunoassay (CLIA) for the quantitative detection of CHI3L1 and its application in hepatitis B virus (HBV)-related liver diseases. The CLIA for CHI3L1 detection presented good analytical performance, with a linear range of 1.50–2000.00 ng/mL and a detection limit of 0.98 ng/mL. To evaluate its clinical application, serum CHI3L1 levels were detected in 82 patients with chronic hepatitis B (CHB) and in 21 healthy controls. The patients with CHB and HCC had higher CHI3L1 levels than the healthy controls and the patients with CHB without HCC. However, CHI3L1 levels did not change significantly with the increase in liver fibrosis stages. The area under the receiver operating characteristic curve for the diagnosis of HBV-related HCC was 0.808, representing a moderate diagnostic value. Correlation analysis revealed a significant association between CHI3L1 and alpha-fetoprotein (AFP) levels, the fibrosis-4 (FIB-4) index, and the aspartate aminotransferase-to-platelet ratio index (APRI). In conclusion, compared with currently reported methods for CHI3L1 detection, the CLIA has a high sensitivity, a wide linear range, and an acceptable accuracy, precision, and reference intervals, making it valuable in the diagnosis of HBV-related HCC. |
| format | Article |
| id | doaj-art-1be6e04740344e6cb0d5ab4a55ce23bc |
| institution | Kabale University |
| issn | 1687-8779 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Analytical Chemistry |
| spelling | doaj-art-1be6e04740344e6cb0d5ab4a55ce23bc2025-02-03T01:32:21ZengWileyInternational Journal of Analytical Chemistry1687-87792024-01-01202410.1155/2024/6688819Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver DiseasesYanqiang Liao0Se Peng1Lesheng Huang2Zhong Li3Jian Hu4Rui Xu5Wenzhi Tang6Jialing Zhuang7Department of Laboratory MedicineDepartment of Laboratory MedicineDepartment of RadiologyZhuhai Seesheen Medical Technology Company LimitedDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineSerum chitinase-3-like protein 1 (CHI3L1) is a diagnostic marker for liver diseases, such as hepatocellular carcinoma (HCC). Herein, we aimed to evaluate the analytical performance of a chemiluminescent immunoassay (CLIA) for the quantitative detection of CHI3L1 and its application in hepatitis B virus (HBV)-related liver diseases. The CLIA for CHI3L1 detection presented good analytical performance, with a linear range of 1.50–2000.00 ng/mL and a detection limit of 0.98 ng/mL. To evaluate its clinical application, serum CHI3L1 levels were detected in 82 patients with chronic hepatitis B (CHB) and in 21 healthy controls. The patients with CHB and HCC had higher CHI3L1 levels than the healthy controls and the patients with CHB without HCC. However, CHI3L1 levels did not change significantly with the increase in liver fibrosis stages. The area under the receiver operating characteristic curve for the diagnosis of HBV-related HCC was 0.808, representing a moderate diagnostic value. Correlation analysis revealed a significant association between CHI3L1 and alpha-fetoprotein (AFP) levels, the fibrosis-4 (FIB-4) index, and the aspartate aminotransferase-to-platelet ratio index (APRI). In conclusion, compared with currently reported methods for CHI3L1 detection, the CLIA has a high sensitivity, a wide linear range, and an acceptable accuracy, precision, and reference intervals, making it valuable in the diagnosis of HBV-related HCC.http://dx.doi.org/10.1155/2024/6688819 |
| spellingShingle | Yanqiang Liao Se Peng Lesheng Huang Zhong Li Jian Hu Rui Xu Wenzhi Tang Jialing Zhuang Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases International Journal of Analytical Chemistry |
| title | Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases |
| title_full | Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases |
| title_fullStr | Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases |
| title_full_unstemmed | Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases |
| title_short | Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases |
| title_sort | analytical and clinical evaluation of a chemiluminescent immunoassay to detect serum chitinase 3 like protein 1 in hbv related liver diseases |
| url | http://dx.doi.org/10.1155/2024/6688819 |
| work_keys_str_mv | AT yanqiangliao analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT sepeng analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT leshenghuang analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT zhongli analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT jianhu analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT ruixu analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT wenzhitang analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases AT jialingzhuang analyticalandclinicalevaluationofachemiluminescentimmunoassaytodetectserumchitinase3likeprotein1inhbvrelatedliverdiseases |